Home LiteratureArticle Details
PMID: 19847397 Published · ppublish English Journal Article

F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection.

Intensive care medicine ·Vol. 36 ·No. 3 ·2010-03-00 ·Pages 504-11

Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG

Abstract

To assess the value of F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) combined with CT in critically ill patients suspected of having an infection. FDG-PET CT scans requested for evaluation of a suspected infection or inflammatory process in critically ill, mechanically ventilated patients were analyzed (blinded for the final clinical diagnosis) and compared with clinical follow-up. Thirty-five FDG-PET/CT scans performed in 33 ICU patients (28 adults and 5 children), median age 58 years (range 1 month-72 years), were analyzed. Twenty-one FDG-PET/CT scans were true positive. Three FDG-PET/CT scans were considered false positive, in one case leading to additional diagnostic procedures (specificity 79%). Additionally, 11 true negatives were found (sensitivity 100%), leading to an overall accuracy of 91%. FDG-PET/CT scanning is of additional value in the evaluation of suspected infection in critically ill patients in whom conventional diagnostics did not lead to a diagnosis. Apart from the high accuracy, in this study it appeared that, in addition to conventional diagnostic techniques that were routinely performed, a normal FDG-PET/CT ruled out important infections requiring prolonged antibiotic therapy or drainage. Since sensitivity is lower in highly metabolic active tissues (e.g., endocarditis, meningitis), the FDG-PET/CT scan is not suited to detect infections in these tissues.

MeSH Terms
Adolescent Adult Aged Child Child, Preschool Critical Illness Female Fever of Unknown Origin/etiology Fluorodeoxyglucose F18 Humans Infant Infant, Newborn Infections/diagnosis Male Middle Aged Netherlands Positron-Emission Tomography/methods Radiopharmaceuticals Retrospective Studies Tomography, X-Ray Computed Young Adult
Chemicals
Radiopharmaceuticals Fluorodeoxyglucose F18
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Simons Koen S
Department of Intensive Care Medicine (632), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Pickkers Peter
Bleeker-Rovers Chantal P
Oyen Wim J G
van der Hoeven Johannes G
References (25)
25 references, click to expand
  1. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
    J Nucl Med. 1994 Oct;35(10):1647-9 PMID: 7931664
  2. Imaging of giant cell arteritis: evidence of splenic involvement using FDG positron emission tomography.
    Clin Nucl Med. 2000 Aug;25(8):633-4 PMID: 10944026
  3. The clinical use of 99m-Tc-labeled WBC scintigraphy in critically ill surgical and trauma patients with occult sepsis.
    Intensive Care Med. 1996 Sep;22(9):867-71 PMID: 8905419
  4. 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease.
    Lancet. 1999 Sep 4;354(9181):836-7 PMID: 10485733
  5. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin.
    Clin Infect Dis. 2001 Jan 15;32(2):191-6 PMID: 11170907
  6. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis.
    J Nucl Med. 1998 Dec;39(12):2145-52 PMID: 9867159
  7. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis.
    Neth J Med. 2003 Oct;61(10):323-9 PMID: 14708910
  8. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET.
    Eur J Nucl Med. 2000 Nov;27(11):1617-25 PMID: 11105817
  9. 18F-FDG PET in detecting metastatic infectious disease.
    J Nucl Med. 2005 Dec;46(12):2014-9 PMID: 16330565
  10. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases.
    Eur J Nucl Med. 2000 May;27(5):524-8 PMID: 10853807
  11. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography.
    Eur J Nucl Med. 1994 Apr;21(4):297-305 PMID: 8005153
  12. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.
    Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):29-37 PMID: 14551752
  13. Inflammatory bowel disease activity measured by positron-emission tomography.
    Lancet. 1997 Jul 26;350(9073):262 PMID: 9242806
  14. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.
    Am J Med. 2004 Jan 1;116(1):50-3 PMID: 14706666
  15. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin.
    Eur J Intern Med. 2004 Jun;15(3):151-156 PMID: 15245716
  16. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states.
    Eur J Nucl Med Mol Imaging. 2006 Aug;33(8):913-8 PMID: 16572304
  17. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings.
    Radiology. 1998 Mar;206(3):749-54 PMID: 9494496
  18. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy.
    Eur J Nucl Med Mol Imaging. 2004 May;31(5):622-6 PMID: 14730403
  19. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies.
    Am J Gastroenterol. 2002 Aug;97(8):1978-85 PMID: 12190164
  20. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis.
    Arch Intern Med. 2001 Apr 9;161(7):1003-7 PMID: 11295964
  21. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data.
    Eur J Nucl Med Mol Imaging. 2003 Sep;30(9):1305-13 PMID: 12811529
  22. Radiolabeled compounds in diagnosis of infectious and inflammatory disease.
    Curr Pharm Des. 2004;10(24):2935-50 PMID: 15379660
  23. Tc-99m HMPAO labelled WBCs in the detection of occult sepsis in the intensive care unit.
    Intensive Care Med. 1992;18(1):15-9 PMID: 1578041
  24. Value of FDG PET in patients with fever of unknown origin.
    Nucl Med Commun. 2001 Jul;22(7):779-83 PMID: 11453051
  25. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.
    Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2320-33 PMID: 18704407
Article Info
Journal
Intensive care medicine
Abbr.
Intensive Care Med
ISSN
1432-1238
Published
2010-03-00
Epub
2009-00-22
Pages
504-11
Language
English
Region
United States
NLM ID
7704851
PMCID
PMC2820225
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com